Journal of Shandong University (Health Sciences) ›› 2020, Vol. 58 ›› Issue (3): 44-51.doi: 10.6040/j.issn.1671-7554.0.2020.179

Previous Articles     Next Articles

Clinical characteristics and treatment effect of 537 cases of novel coronavirus pneumonia in Shandong Province

ZHOU Shengyu1,2, WANG Chunting3, ZHANG Wei4, WANG Ximing5, DONG Liang1   

  1. 1. Department of Pulmonary and Critical Care Medicine, Qilu Hospital of Shandong University, Jinan 250012, Shandong, China;
    2. School of Nursing, Shandong University, Jinan 250012, Shandong, China;
    3. Department of Critical Care Medicine, Shandong Provincial Hospital, Jinan 250021, Shandong, China;
    4. Department of Lung Disease, Affiliated Hospital of Shandong University of Traditional Chinese Medicine, Jinan 250011, Shandong, China;
    5. Department of Radiology, Shandong Provincial Hospital, Jinan 250021, Shandong, China
  • Online:2020-03-10 Published:2022-09-27

Abstract: Objective To provide valuable references for improving the diagnosis and treatment of novel coronavirus pneumonia in Shandong Province. Methods Clinical data of novel coronavirus pneumonia(NCP)patients in Shandong Province until February 15, 2020 were summarized and analyzed to investigate their epidemiological and clinical features and treatment effect. Furthernore, the clinical data of four typical cases were presented in detail. Results The characteristics of the epidemic, clinical symptoms and treatment were basically consistent with the national data. The vast majority of patients were mild, a few were severe, and very few were critically ill because of severe underlying diseases. Clinical features were mainly fever, dry cough, normal or decreased levels of white blood cells, about 50 percent of cases with reduced lymphocyte count, and ground glass opacity in lung in the early stage. The treatment effect was generally satisfactory. Senility and underlying diseases were important risk factors for severe illness. Closely observing the signs of disease progression and early intervention could reduce mortality. Coclusion The incidence of NCP in Shandong Province is relatively high, but the majority are common type, and the severe type is lower than the national average level outside Hubei Province. The survival rate of severe case is high, and the mortality is lower than the national average level outside Hubei Province. The therapeutic experience of Shandong Province should be promoted and applied in China.

Key words: Shandong Province, Novel coronavirus pneumonia, Clinical characteristics, Treatment effect

CLC Number: 

  • R563.1
[1] Paules CI, Marston HD, Fauci AS. Coronavirus infections-more than just the common cold[J]. JAMA, 2020. doi:10.1001/jama.2020.0757.
[2] Hui DS, I Azhar E, Madani TA. et al. The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health—The latest 2019 novel coronavirus outbreak in Wuhan, China[J]. Int J Infect Dis, 2020: 264-266. doi: 10.1016/j.ijid.2020.01.009.
[3] 武汉市卫生健康委员会. 武汉市卫健委关于当前我市肺炎疫情的情况通报[EB/OL].(2019-12-31)[2020-02-19].http://wjw.wuhan.gov.cn/front/web/showDetail/2019123108989.
[4] WHO. Novel coronavirus-China[EB/OL].(2020-01-12)[2020-02-19]. http://www.who.int/csr/don/12-january-2020-novel-coronavirus-china/en/.
[5] 国卫办医函. 关于印发新型冠状病毒感染的肺炎诊疗方案(试行第二版)的通知[EB/OL]. http://www.nhc.gov.cn/yzygj/ggwsylglc/new_list_2.shtml.
[6] 国卫办医函. 关于印发新型冠状病毒感染的肺炎诊疗方案(试行版)的通知[EB/OL]. http://www.nhc.gov.cn/yzygj/ggwsylglc/new_list_2.shtml.
[7] 国卫办医函. 《国家卫生健康委办公厅关于印发新型冠状病毒的肺炎诊疗方案(试行第二版)和全国各省(区、市)首例新型冠状病毒感染的肺炎病例确认程序的通知》[EB/OL].(2020-01-18)[2020-02-19].http://www.nhc.gov.cn/yzygj/ggwsylglc/new_list_2.shtml.
[8] Jin YH, Cai L, Cheng ZS, et al. A rapid advice guideline for the diagnosis and treatment of 2019 novel coronavirus(2019-nCoV)infected pneumonia(standard version)[J]. Mil Med Res, 2020, 7(1): 4. doi:10.1186/s40779-020-0233-6.
[9] 国卫办医函. 关于印发新型冠状病毒肺炎诊疗方案(试行第五版 修正版)的通知[EB/OL].(2020-02-08)[2020-02-19]. http://www.nhc.gov.cn/yzygj/s7653p/202002/d4b895337e19445f8d728f-caf1e3e13a.shtml.
[10] Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China[J]. Lancet, 2020, 395(10223): 497-506.
[11] Chen N, Zhou M, Dong X. et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study[J]. Lancet, 2020, 395(10223): 507-513.
[12] Guan, WJ, Ni ZY, Hu Y, et al. Clinical characteristics of 2019 novel coronavirus infection in China[J]. N Engl J Med, 2020. doi: 10.1056/NEJMoa2002032.
[13] Wang G, Jin X. The progress of 2019 novel coronavirus event in China[J]. J Med Virol, 2020. doi:10.1002/jmv.25705.
[14] 国卫办医函. 关于印发新型冠状病毒感染的肺炎诊疗方案(试行第三版)的通知[EB/OL].(2020-01-22)[2020-02-19]. http://www.nhc.gov.cn/yzygj/s7653p/202001/f492c9153ea9437bb-587ce2ffcbee1fa.shtml.
[15] 国卫办医函. 关于印发新型冠状病毒感染的肺炎诊疗方案(试行第四版)的通知[EB/OL].(2020-01-27)[2020-02-19]. http://www.nhc.gov.cn/yzygj/s7653p/202001/4294563ed35b432-09b31739bd0785e67.shtml.
[16] Arabi YM, Shalhoub S, Mandourah Y, et al. Ribavirin and interferon therapy for critically Ill patients with Middle East respiratory syndrome: a multicenter observational study[J]. Clin Infect Dis, 2019. doi: 10.1093/cid/ciz544..
[17] Zumla A, Bates M, Maeurer M. Corticosteroid therapy for pneumonia[J]. Lancet, 2015, 386(9997): 955. doi:10.1016/s0140-6736(15)00065-3.
[18] Ling Y, Xu SB, Lin YX, et al. Persistence and clearance of viral RNA in 2019 novel coronavirus disease rehabilitation patients[J]. Chin Med J(Engl), 2020. doi:10.1097/cm9.0000000000000774.
[19] Arabi YM, Arifi AA, Balkhy HH, et al. Clinical course and outcomes of critically ill patients with Middle East respiratory syndrome coronavirus infection[J]. Ann Intern Med, 2014, 160(6): 389-397.
[1] KONG Xinxin, SUN Shuzhen, LI Qian, CHEN Yuan, ZHOU Aihua, WANG Li, YAO Xiujun. Analysis of 7 cases of anti-H factor antibody-positive hemolytic uremic syndrome [J]. Journal of Shandong University (Health Sciences), 2022, 60(4): 82-86.
[2] LUO Yingshu, LI Bin, XU Changqin, JIANG Junmei, XU Hongwei. Evaluation of the efficacy and complications of endoscopic treatment of 240 cases of upper gastrointestinal submucosal tumors [J]. Journal of Shandong University (Health Sciences), 2021, 59(3): 74-80.
[3] FU Yilin, GUO Tian, GONG Ying, YAO Zhenyu, GUAN Qingbo, XU Chao, ZHOU Xinli, ZHANG Haiqing, ZHENG Dongmei, LIU Luna, ZHAO Jiajun. Retrospective analysis of causes and clinical characteristics of 554 cases with hypokalemia in endocrinology department: a single-center study [J]. Journal of Shandong University (Health Sciences), 2021, 59(10): 39-46.
[4] JU Xiuli. Potential mechanism and research progress of mesenchymal stem cells in the treatment of 2019 novel coronavirus pneumonia [J]. Journal of Shandong University (Health Sciences), 2020, 58(3): 32-37.
[5] CUI Liangliang, GENG Xingyi, ZHAO Xiaodong, YANG Guoliang, CHANG Caiyun, ZHAO Mengjiao, LI Zhan, WANG Chunrong, LIU Lanzheng, RUAN Shiman. Reflection and epidemiological characteristics of coronavirus disease 2019 in Jinan City [J]. Journal of Shandong University (Health Sciences), 2020, 58(3): 52-57.
[6] ZHANG Xiaoguo, MA Yan, XIAO Jiaan, ZHANG Zhongfa. Clinical characteristics of novel coronavirus pneumonia in children in Jinan [J]. Journal of Shandong University (Health Sciences), 2020, 58(3): 62-64.
[7] WANG Bin, BU Xuehui, KONG Xianggen, ZHANG Zhaohua, WU Anzhao, XIAO Di, JIANG Xuemei. Comparison of the clinical characteristics between 37 adults and 10 children with COVID-19 [J]. Journal of Shandong University (Health Sciences), 2020, 58(10): 112-116.
[8] LIU Guanyi, YANG Liyuan, FU Zhentao, XU Aiqiang, GUO Xiaolei. Incidence and mortality of oral cancer in Shandong Province in 2014 [J]. Journal of Shandong University (Health Sciences), 2019, 57(7): 102-107.
[9] HE Dongyang, SUN Jiyao, WANG Meng, WANG Jian, HUANG Guo. Comparison of the characteristics of inpatients’ disease distribution in a tertiary hospital in Shandong Province in 2006 and 2016 [J]. Journal of Shandong University (Health Sciences), 2018, 56(4): 81-86.
[10] NIE Siyue, WANG Zhen, SUN Jingyu, LIU Jie, LI Juan, WEI Xiaojuan, LU Chunxiao, L(¨overU)Xingyan, WANG Shuyun, SUN Yuping. Expression and clinical significance of angiopoietin-like protein 5 in human gastric cancer tissues [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2017, 55(8): 61-65.
[11] WANG Meijian, HOU Xinguo, LIANG Kai, CHEN Li. Serum lipids and lipoproteins in middle-aged and elderly Chinese in Shandong Province [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2017, 55(5): 70-75.
[12] YANG Ding,YANG Peng, LI Yubo, SUN Qiang. Changes in prescriptions for upper respiratory tract infections in Z county of Shandong Province:a panel data analysis of 8 village clinics [J]. Journal of Shandong University (Health Sciences), 2017, 55(12): 88-94.
[13] LI Yan, LIU Kun, SUN Xiaojie. Health inequality related to income and influencing factors of the rural elderly in three counties of Shandong Province [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2016, 54(6): 91-96.
[14] WANG Xing, ZHANG Xiyu, LIN Weiwei, LIAN Ying, ZHANG Qingqing, LI Qilong, LI Shixue. Present situation and existing problems of telemedicine in Shandong Province [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2016, 54(2): 90-94.
[15] WANG Guangjie, ZU Shulu, ZHANG Xiulin, XU Zhishun, ZHOU Chunwen, LIU Yuqiang, WANG Shaoyong. Von Hippel-Lindau disease complicated with renal carcinoma: a report of 2 cases [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2016, 54(2): 86-89.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
No Suggested Reading articles found!